BioCentury
ARTICLE | Company News

Sanofi, Rib-X in antibiotic deal

July 7, 2011 12:18 AM UTC

Rib-X Pharmaceuticals Inc. (New Haven, Conn.) partnered with Sanofi (Euronext:SAN; NYSE:SNY) to discover and develop antibiotic candidates against a 20 angstrom unit of the ribosomal 50S subunit to tr...